Michael D. Dalzell/Editing Samples



Some of the lessons of the COVID-19 pandemic will not be known for years, but one thing was abundantly clear at an early stage: The U.S. healthcare system is not set up to tolerate major disruption. The crisis exposed shortcomings in readiness and misaligned priorities among stakeholders. “Business as usual” will never be the same. I helped the authors of this series of white papers to articulate the teachable moment and their vision of how providers, payers, and pharmaceutical companies can rethink relationships to improve delivery of patient-focused